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ABSTRACT
Chlamydia trachomatis (CT) infection is often silent and can lead to long-term 
reproductive complications in women. In this study, we determined the prevalence of CT 
infection and possible associations between the presence of the infection and clinical-
epidemiological variables in pregnant women attended at the Basic Health Units of the Coari 
city, Amazonas, Brazil. From July 2016 to March 2017, 164 pregnant women undergoing 
prenatal care were recruited. One hundred of these women were tested for CT infection using 
two types of samples: cervico-vaginal and urine. The diagnosis was confirmed by PCR with 
primers specific for the omp1 gene of CT chromosomal DNA. Of the 100 pregnant women, 
18 (18%) had CT infection, 8 (8%) of which were positive in both samples, 7 (7%) only in 
the urine sample and 3 (3%) only in cervical-vaginal sample. There was moderate agreement 
(Kappa=0.55) and no statistically significant difference between sample types (p = 0.400). 
The mean age of infected women was 21.1 years (SD = 4.6). Of the clinical-epidemiological 
variables analyzed, “more than 2 partners in the last 12 months” (p = 0.022) and gynecological 
complaint of “pain after intercourse” (p = 0.020) were associated with CT infection. This 
study showed a high prevalence (18%) of CT infection among pregnant women in Coari / 
Amazonas. Urine sampales were as good as cervical-vaginal ones for the screening of CT 
infection during the prenatal period.
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INTRODUCTION
Pregnancy is a time of many changes in a woman’s life, including hormonal 
and physiological changes and reduced immune activity, making her vulnerable 
to infections. Women, therefore, are more likely to acquire Sexually Transmitted 
Infections (STI) during pregnancy1. Among sexually transmitted pathogens, 
Chlamydia trachomatis (CT) infection is one of the most common, being associated 
with problems in women’s reproductive health. Fifty to 80% of women infected 
with CT do not develop symptoms; these women are considered silent reservoirs 
of the pathogen and continue to transmit it sexually. The untreated infection allows 
CT propagation to the upper genital tract, which can lead to pelvic inflammatory 
disease (PID), ectopic pregnancy and infertility. During pregnancy, CT infection 
can lead to rupture of membranes, premature labor, miscarriage, low birth weight, 
conjunctivitis and neonatal pneumonia, among other complications2-4.
Brazilian epidemiological studies show that CT infection rates in pregnant 
women range from 6.9% to 18%5-7, and studies specifically conducted in the Amazon 
show a prevalence of CT infection in pregnant women of about 11%8,9. Countries 
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such as Germany, Bulgaria, Bahamas, Canada, Estonia, 
Japan, Romania and Sweden are screening for prenatal CT 
infection in order to avoid pregnancy complications10,11. 
Other countries, such as Australia, the United States, New 
Zealand and Latvia, restrict prenatal screening of pregnant 
women aged ≤ 25 years and the ones at high risk12. In 
Brazil, public and private services do not routinely screen 
CT infection, even in pregnant women1.
Urban areas of the Brazilian Amazon inland cities have 
no studies on CT infection rates in pregnant women. These 
urban areas located within the extensive territory of the 
Brazilian Amazon have a very precarious health system, and 
besides that, there are many isolated small villages, where 
access is possible only by river or little seaplanes, making 
it difficult for pregnant women to access adequate health 
services. Spontaneous abortions are frequent, and neonatal 
deaths are common due to the lack of human resources and 
adequate health care infrastructure for premature newborns. 
Also due to the great extent of the Amazonian territory, 
premature newborns depend on air transportation to the 
capital (Manaus) in order to receive intensive neonatal care, 
further increasing the difficulties and costs of the process. 
Therefore, knowing the epidemiology of CT infection 
in this population and seeking measures that may help 
reducing these complications are necessary. In this study, 
we determined the prevalence of CT infection in cervical 
and urine specimens of pregnant women attending prenatal 
care at the Basic Health Units of the city of Coari / Amazon.
MATERIALS AND METHODS
Study setting and population
Coari city, with a territorial area of 57,970,768 km2, is 
in the region of the medium Solimoes (Solimoes River), 
360 km away from the capital of Amazonas (Manaus). 
Its current estimated population is 84,000 inhabitants13. 
The estimated minimum number of pregnant women for 
this study was 58, based on the number of 1,729 births 
in the year 201314, and an expected prevalence of STI of 
1.4% (according to data from DATASUS of STI infection 
in pregnant women of Coari in the year 2013), with a 
margin of error of 3% and 95% confidence interval. Basic 
Health Units (BHU) are places in which pregnant women 
perform prenatal care and there is infrastructure for the 
collection of vaginal samples. There are 12 BHU in Coari 
city that attend the urban population, and all of them were 
visited between July 2016 and March 2017. The inclusion 
criteria were: pregnant women in the second trimester of 
pregnancy (14 to 27 weeks), in order to minimize the risk 
of any association between collection and adverse events 
such as bleeding disorders, miscarriage, preterm delivery, 
premature rupture of membranes, among others, without 
maternal age limitation. Exclusion criteria were: any clinical 
situation of risk for gestation, such as vaginal bleeding, 
history of accidental fall, placenta previa, loss of amniotic 
fluid, dilation of the cervix, among others. 
The total number of pregnant women registered was 
164, of which 100 participated in the study. Of the 64 
pregnant women who did not participate, 52 accepted the 
invitation made during visits to their homes but did not 
attend the scheduled sample collection, even after t the 
consultation was rescheduled. Twelve women were not 
able to participate because they presented some clinical 
condition of risk for the samples collection (according to 
exclusion criteria).
Study type and specimens
This is a descriptive and cross-sectional study, approved 
by the Research Ethics Committee of the Federal University 
of Amazonas (CAAE 50907415.3.0000.5020). The 164 
registered pregnant women were visited in their homes. 
Those who accepted to participate and met the inclusion 
criteria were included after signing the consent form and 
answering a clinical-epidemiological questionnaire, totaling 
100 women. On the days scheduled by BHU’s professionals, 
the first urine of the day (20mL) from pregnant women was 
collected in a sterile cup. A cervical-vaginal sample was also 
collected (endocervix, ectocervix and vaginal wall) with 
the aid of a vaginal speculum and a swab. The swab was 
immersed in TRIS-EDTA (TRIS-HCl 10 mM and EDTA 
1mM pH 8,0) buffer and the samples were transported in a 
thermal box (2 °C to 8 °C) and stored in the laboratory at 
-20 °C until processed. 
Processing of samples
In a 15 mL falcon tube 14 mL of urine sample were 
centrifuged at 2,000 g for 20 min. The supernatant was 
discarded and the pellet was washed with PBS (Phosphate 
- Buffered Saline). The cervical-vaginal samples were 
vortexed and then 1 mL was transferred to a microtube. 
DNA extraction of urine and cervical-vaginal samples were 
performed using the commercial QIAamp Viral RNA Mini 
Kit (QIAGEN, Germany), according to the manufacturer’s 
recommendations. 
CT detection
CT detection was performed by PCR using the primer pair 
CT05/CT06 (5’-GAT AGCCAGCACAAAGAGAGCTAA 
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-3’/5’- TTTGTTTTCGACCGTGTTTTG CAAACA 
GATGTGAA -3’), which amplify a 280 bp region of the 
MOMP gene located within chromosomal DNA15. As the 
internal control of reactions the primers PCO3+/PCO4+ 
were used (5’-CTTCTGACACAACTGTGTTCACTA
GC-3’/5’ TCACCGCAACTTCATCCACGTTCACC-3’), 
which amplify a 110 bp fragment of the human β-globin 
gene16 were used. The final volume of the reaction was 
25 μL, containing 5 U of Platinum Taq DNA polymerase 
High Fidelity (Invitrogen, USA), 5 pmol of each primer, 
2.5 μL of 10X reaction buffer, 50 mM MgSO4, 10 mM dNTP, 
5.0 μL of sample DNA and sterile water. Amplification was 
performed in a thermal cycler, under the following cycling 
conditions: initial denaturation of 94 °C for 30s, followed 
by 40 cycles of 94 °C for 30s, 58 °C for 1 min 30s, 68 °C 
for 2 min and a final extension of 68 °C for 5 min. In each 
reaction, a previously known CT positive control and a 
negative control with water instead of DNA were used. 
The amplified products were visualized on 1.5% agarose 
gel stained with ethidium bromide (1 μg / μL).
Statistical analysis
Data were tabulated in an electronic file created in 
the free Epi-Info program (v.7.2.1.0) (Center of Disease 
Control and Prevention – CDC)17. Statistical analysis was 
performed in the BioEstat program (v.5.0)18. Associations 
of CT infection and sociodemographic as well as behavioral 
characteristics were assessed using the chi-square test or 
the Fisher’s Exact test. Statistical significance was set at 
p < 0.05. To evaluate the agreement between the two types 
of samples, the Kappa coefficient was used. Excellent 
agreement was defined as Kappa > 0.7519.
RESULTS
The human β-globin gene fragment was amplified by 
PCR in all 100 DNA samples from pregnant women who 
participated in this study, both in urine and in cervical-
vaginal samples, confirming the inexistence of amplification 
inhibitors in the DNA samples. The prevalence rate of 
CT infection was 18% (18/100). The prevalence of CT in 
urine samples was 15% (95% CI: 8.65 - 23.53) and in the 
cervical-vaginal samples was 11% (95% CI: 5.62 - 18.83). 
No significant difference was found between the two 
sample types (p= 0.400) (Table 1) and the Kappa coefficient 
calculated to evaluate the agreement among the samples 
was 0.55, showing a moderate agreement.
The patients’ ages ranged from 13 to 41 years; the mean 
age was 22.9 years (SD 6.24). The majority of participants 
had low educational level (less than nine years of study), 
were married, reported two or more sexual partners in life, 
with the average age of the first intercourse of 15.2 years 
(SD = 2.19). The sociodemographic, behavioral and 
clinical characteristics of the studied population are in 
Table 2. These characteristics were analyzed in relation 
to CT infection and a statistically significant association 
of this infection was found with pregnant women who 
had had two or more sexual partners in the last 12 months 
(p=0,022) and who had a gynecological complaint of “pain 
after intercourse” (0,020) (Table 3).
DISCUSSION
Chlamydia trachomatis (CT) infection is almost 
always asymptomatic so that infected people usually do 
not know their infection status and do not seek treatment. 
This chronic infection can cause long-term complications, 
including some related to the gestational period. CT-infected 
pregnant women may undergo preterm labor, premature 
rupture of membranes or give birth to low birth weight 
newborns. Infants born to mothers with CT may be infected 
during labor through the vaginal canal and thereby develop 
conjunctivitis and/or pneumonia3.
This is the first study to detect CT in pregnant women 
in Coari city. In this town, a previous study was carried out 
with 361 sexually active women over 18 years of age who 
sought the BHU for routine gynecological appointment, 
and a prevalence of 6.4% of STI was found, a prevalence 
lower than those found in other Brazilian cities with 
similar population samples20. In our study with pregnant 
women, when we consider as positive any of the two type 
of sample (urine or cervical-vaginal), the prevalence of 
CT infection was 18%. In urine samples the prevalence 
of CT infection was 15%, which is among the highest 
rates found in pregnant women in studies conducted both 
in Brazil and in other countries. In Brazilian studies, 
we found rates of CT infection in urine samples from 
pregnant women ranging from 6.9% to 18%5,6 and in other 
countries a prevalence between 6.4 and 18.1%21-23. In the 
cervical-vaginal samples, the prevalence of CT infection 
was 11% in our study, similar to the results found in other 
Table 1 - Frequency of CT infection positivity in biological 
samples from 100 pregnant women recruited in the Basic Health 





Cervical 11 89 11% (5.62 – 18.83) 0.400*
Urine 15 85 15% (8.65 – 23.53)
*Chi-square test
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studies conducted in Brazil or abroad using this type of 
sample7-9,24,25.
These two types of sample appear to be equivalent 
for the diagnosis of CT by PCR. In our study, a moderate 
concordance was found between the samples (kappa = 
0.55), and no statistically significant difference was found 
among these results (p = 0.400). In the study by Fang et al.26, 
using urine samples, endocervical swab and vaginal swab 
collected by the participants, the authors found an excellent 
concordance between results (Kappa = 0.89). Regarding 
sensitivity and specificity, other studies have shown that 
urine and vaginal samples are equivalent for the diagnosis of 
CT and they emphasized the importance of using urine for 
the routine screening of CT infection27,28. In this way, urine 
samples are an excellent choice for the diagnosis of CT in 
pregnant women, since it is self-sampled, noninvasive and 
is already routinely used for detection of other infections 
during prenatal care29,30. 
In our study, we believe that the high rate of non-
attendance of pregnant women (52 women) may be 
related to the discomfort and anxiety that cervical-vaginal 
collections always cause in women. If in our study we had 
used only urine, perhaps the refusal rate would not have 
been so high.
Both, Hybrid Capture (HC) method and PCR have been 
used for diagnosis of CT infection. In Brazil, the HC test has 
already been approved by the National Agency of Sanitary 
Surveillance (Agência Nacional de Vigilância Sanitária - 
ANVISA), and the Unified Health System (Sistema Único 
de Saúde - SUS) and included in the list of paid procedures. 
However, studies have shown that the sensitivity of the HC 
test ranges from 66.7% to 72.3% when compared to PCR, 
being inappropriate for CT screening due to this moderate 
sensitivity31.
The PCR technique allows the amplification of 
DNA from minimal amounts of the CT DNA with high 
sensitivity and specificity, although with higher cost. 
Primers used in PCR for detection of CT may target 
plasmid DNA, omp1 gene in chromosomal DNA and 
16S ribosomal gene. Many studies have used primers 
for plasmid DNA since there are 7 to 10 copies of it per 
bacterium, making the technique more sensitive. However, 
a study by Farencena et al.32 described the isolation of a 
CT devoid of plasmid and Ripa and Nilsson33, in Sweden, 
found a strain that had a 377 bp deletion in plasmid DNA 
between nucleotides 608 and 985 (known as the “Swedish 
variant”). In our study, to reduce the likelihood of false 
negative results , we used a primer pair for the omp1 
gene, which is in chromosomal DNA coding for the main 
protein of the outer membrane of the bacterium, within a 
conserved region in all CT serotypes15.
Table 2 - Distribution of pregnant women recruited at the Basic 
Health Units of Coari city, Amazon, Brazil, according to socio-
demographic, behavioural and clinical characteristics.
Variables (n=100) n %
Age (years)




Married/Stable union 78 78.0
Age at first sexual intercourse (years)
Mean ± SD 15.17 ± 2.19
Amplitude 9-23
Education (years)
< 9 (primary/intermediate) 52 52.0
≥ 9 (secondary/higher) 48 48.0








Number of sexual partners over a 
lifetime
1 20 20.0
≥ 2 80 80.0
Numbers of sex partners in last 
12 months
1 77 77.0







History of preterm birth (n=52)
Yes 08 8.0
No 44 44.0
Clinical complaints (n=69) b
Pruritus 15 21.7
Vaginal discharge 45 65.2
Pelvic pain 35 50.7
Difficulty urinating 06 8.7
Pain after intercourse 02 3.0
a
 Minimum wage at the time of the study was 880.00 approxi-
mately 286 dollars; b It does not add up because more than one 
clinical complaint may occur.
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Regarding the epidemiological profile of infected 
women, our results shave shsown that the mean age of 
infected pregnant women was lower than the uninfected 
ones (21.15 ± 4.65 e 23.08 ± 6.36, respectively), but with 
no statistically significant difference between groups 
(p=0,226). Studies have shown that CT infection was 
found predominantly in pregnant women up to 25 years 
old5,7,21,34,35, showing that young women are at higher risk 
of acquiring this infection, which was also observed in 
this study. Studies have shown that the highest rates of 
CT infection are found in developing countries, among 
poorer and least educated5,6,36 people, and this finding is in 
agreement with our results: our tested group is composed 
of women living in a poor and geographically isolated 
urban center, an inland town in the State of Amazonas, 
located in the Northern region of Brazil. Brazil is a country 
Table 3 - Sociodemographic, behavioral and clinical characteristics of pregnant women recruited at the Basic Health Units of Coari 
city, Amazon, Brazil, in relation to CT infection.
Variables (n=100)
Chlamydia identification
Negative (n=82) Positive (n=18)
Total P
n % n %
Age (years) 0,226c
Mean ± SD  23.08 ± 6.36 21.15 ± 4.65 22.87 ± 6.24
Marital status 0.165b
Single 16 72.7 06 27.3 22
Married/Stable union 66 84.6 12 15.4 78
Age at first sexual intercourse (years) 0.190c
Mean ± SD  15.30 ± 2.33 14.55 ± 1.29 15.17 ± 2.19
Education (years) 0.392a
< 9 (primary/intermediate) 41 50.0 11 61.11 52
≥ 9 (secondary/higher) 41 50.0 07 38.9 48
Number of sexual partners over a lifetime 0.491b
1 17 85.0 03 15.0 20
≥ 2 65 81.2 15 18.8 80
Numbers of sex partners in last 12 months 0.022b
1 67 87.0 10 13.0 80
≥ 2 15 65.2 08 34.8 20
Number of pregnancies 0.851a
Primitive 39 81.2 09 18.8 48
>1gestation 43 82.7 09 17.3 52
Abortion story (n=52) 0.110b
Yes 08 66.7 04 33.3 12
No 35 87.5 05 12.5 88
History of preterm birth (n=52) 0.578b
Yes 07 87.5 01 12.5 8
No 36 81.8 08 18.2 44
Clinical complaints (n=69)
Pruritus 13 86.7 02 13.3 15 0.11d
Vaginal discharge 35 77.8 10 22.2 45 0.55d
Pelvic pain 30 85.7 05 14.3 35 0.27d
Difficulty urinating 06 100 00 00 06 1.00d
Pain after intercourse 01 50.0 01 50.0 02 0.05d
N= Number of patients; Sd= standard deviation; aChi-square test; b Ficher’s exact test; c student test;d binominal test
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of continental dimensions, showing great discrepancy in 
socioeconomical indexes between the South and the North 
of the country; and excepting for State capitals, most people 
living in cities of the Northern Region of Brazil have low 
levels of education and more difficult access to basic health 
services37. Most women in our study had monthly family 
income below R$ 880 (equivalent to about $286) and 
52%reported having studied less than 9 years.
Some studies have shown that the prevalence of 
infection tends to be higher in single women and in those 
with different partners5,20,34,35. In our study, the prevalence 
of infection was higher in single women (27.3%) than 
in women living with fixed partners (15.4%), although 
differences were not statistically significant (p=0.165). 
The main risk factor for CT infection in this study was 
the highest number of partners in the last 12 months, with 
a prevalence of 44.4% among women who reported this 
condition. In this population, considering the history of 
preterm birth and spontaneous abortion - clinical outcomes 
related to CT infection - our study found no association 
between CT infection and these variables, which is in 
agreement with some Brazilian studies that also fail to 
find these associations6,7. On the contrary, other authors 
clearly found association between these variables and CT 
infection4,5. Although no association of CT infection with 
such of the outcomes was found, we consider that CT 
infections in these women may be recent and may still cause 
undesirable outcomes in future pregnancies. 
CONCLUSIONS
In Brazil, during prenatal care, the routine screening 
of HIV, syphilis, hepatitis B and C, toxoplasmosis and 
rubella among pregnant women is recommended by the 
Brazilian Ministry of Health and it is performed. The high 
prevalence (18%) found in our study helps to increase the 
visibility of the problem of CT infection during pregnancy 
and reinforces the importance of including CT screening in 
prenatal care routine in Brazil. Screening for CT infection 
during prenatal care using urine samples and PCR (or even 
HC) as the diagnostic method is an opportunity to detect 
and treat women, to reduce the harm to the mother and 
child, as well as expenses with the undesirable outcomes. 
We consider that there is a need for cost effectiveness 
studies the inclusion of CT screening in prenatal care in 
Brazil.
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